| Jun-02-23 05:30AM |
Better Healthcare AI Stock: Moderna vs. DoximityThe Motley Fool |
| Jun-01-23 08:00AM |
COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?The Motley Fool |
| May-31-23 05:30AM |
2 Healthcare AI Stocks to Buy on the DipThe Motley Fool |
| May-30-23 07:00AM |
If You Invested $2,500 in Moderna in 2019, This Is How Much You Would Have TodayThe Motley Fool |
| May-07-23 03:13AM |
Is Moderna a Value Stock to Buy Right Now?The Motley Fool |
| May-06-23 05:30AM |
Is Moderna Building a Respiratory Vaccine Empire?The Motley Fool |
| May-04-23 11:21AM |
‘COVID is not going away’: Moderna posts surprise quarterly profit as it looks to fall vaccinations MarketWatch |
| 08:49AM |
Here's when history says the post-Fed pause rally should start — and the two unlikely sectors to benefitMarketWatch |
| May-04-23 08:05AM |
Moderna (MRNA) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research |
| 07:29AM |
Here's when history says the post-Fed pause rally should start — and the two unlikely sectors to benefitMarketWatch |
| May-04-23 07:00AM |
US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism'Benzinga |
| 05:57AM |
These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020The Motley Fool |
| May-04-23 04:50AM |
U.S. stock futures see volatile trading on Fed and bank angst; Apple results loomMarketWatch |
| May-03-23 11:46AM |
Drug, Biotech Stocks' Q1 Earnings on May 4: REGN, ZTS & MoreZacks Investment Research |
| 08:34AM |
Should You Buy Moderna (MRNA) Ahead of Earnings?Zacks Investment Research |
| May-02-23 02:00AM |
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?The Motley Fool |
| 12:06PM |
Vertex (VRTX) Q1 Earnings Top Estimates, Revenues Up Y/YZacks Investment Research |
| May-02-23 06:10AM |
The Zacks Analyst Blog Highlights Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and RollinsZacks Investment Research |
| May-01-23 12:40PM |
Will Pfizer (PFE) Beat Expectations This Earnings Season?Zacks Investment Research |
| 09:17AM |
Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth StockThe Motley Fool |
| May-01-23 12:01PM |
Blockbuster IPOs Are Coming To Push The Rally HigherSeeking Alpha |
| Apr-28-23 08:25AM |
Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?Zacks Investment Research |
| 05:30AM |
Better Healthcare AI Buy: Moderna vs. MedronicThe Motley Fool |
| Apr-27-23 10:02AM |
Moderna (MRNA) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research |
| 09:00AM |
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research |
| Apr-27-23 05:25AM |
3 Stocks That Could Be Worth More Than Berkshire Hathaway by 2030The Motley Fool |
| Apr-26-23 03:00AM |
Expert Ratings for ModernaBenzinga |
| 02:00AM |
Better Buy: Pfizer vs. ModernaThe Motley Fool |
| Apr-26-23 11:00AM |
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023Benzinga |
| Apr-25-23 08:33AM |
Is Moderna Setting Expectations Too High?The Motley Fool |
| Apr-20-23 10:22AM |
What's Going On With IBM Stock Today?Benzinga |
| 09:24AM |
Where Will Moderna Be in 1 Year?The Motley Fool |
| Apr-20-23 06:00AM |
Is Moderna About to Face the Same Challenge as Other Biotechs?The Motley Fool |
| 05:30AM |
3 Things About Pfizer That Smart Investors KnowThe Motley Fool |
| Apr-17-23 08:58AM |
'Gradually, then suddenly.' Earnings expectations may be about to drop, says Morgan Stanley strategist.MarketWatch |
| 05:30AM |
This Prediction May Completely Change Your Opinion of ModernaThe Motley Fool |
| Apr-14-23 10:57AM |
Drug manufacturer Catalent's stock tumbles 25% after profit warning and CFO departureMarketWatch |
| 09:26AM |
3 Medical Stocks With Solid Growth Potential to Keep Track OfZacks Investment Research |
| Apr-14-23 09:00AM |
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to KnowZacks Investment Research |
| 06:20AM |
Is Invesco S&P 500 Equal Weight ETF (RSP) a Strong ETF Right Now?Zacks Investment Research |
| Apr-14-23 05:30AM |
Is It Too Late to Buy Pfizer Stock?The Motley Fool |
| Apr-13-23 11:22AM |
Biotech Stock Roundup: MRNA Provides Update, KALA, IFRX Surge on Regulatory NewsZacks Investment Research |
| 08:34AM |
Moderna, ConocoPhillips, Vertex Pharmaceuticals And This ETF: CNBC's 'Final Trades'Benzinga |
| Apr-13-23 06:40AM |
Buffett Thinks This Is the Most Important Quality an Investor Can HaveThe Motley Fool |
| 05:52AM |
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?The Motley Fool |
| Apr-12-23 03:12AM |
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'Benzinga |
| 11:47AM |
Moderna (MRNA) Posts 2027 Biz View, Down 3% on Flu Jab SetbackZacks Investment Research |
| Apr-12-23 09:36AM |
Moderna Extends YTD Drop on Mixed Early Flu Shot DataInvesting.com |
| 09:22AM |
Company News for Apr 12, 2023Zacks Investment Research |
| Apr-12-23 07:25AM |
Moderna is developing a Lyme disease vaccine in a first for the company MarketWatch |
1.55%
+1.99
NameModerna INC
SectorHealthcare (1499)
IndustryBiotechnology (867)
Web
Phone617-714-6500
Employee680
Twitter
@moderna_tx
SEC filings
Latest SEC Filings
Address200 Technology Square, Cambridge, United States (2139)